These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9564764)

  • 21. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manipulating the contractile apparatus: genetically defined animal models of cardiovascular disease.
    Dalloz F; Osinska H; Robbins J
    J Mol Cell Cardiol; 2001 Jan; 33(1):9-25. PubMed ID: 11133219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children.
    Greber-Platzer S; Marx M; Fleischmann C; Suppan C; Dobner M; Wimmer M
    J Mol Cell Cardiol; 2001 Jan; 33(1):141-8. PubMed ID: 11133230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
    Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
    J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between polymorphisms G395A in promoter and C1818T in exon 4 of the KLOTHO gene with glucose metabolism and cardiovascular risk factors in Korean women.
    Rhee EJ; Oh KW; Yun EJ; Jung CH; Lee WY; Kim SW; Baek KH; Kang MI; Park SW
    J Endocrinol Invest; 2006; 29(7):613-8. PubMed ID: 16957409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-->Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure.
    Ko YL; Chen JJ; Tang TK; Cheng JJ; Lin SY; Liou YC; Kuan P; Wu CW; Lien WP; Liew CC
    Hum Genet; 1996 May; 97(5):585-90. PubMed ID: 8655135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
    Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
    Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function.
    Sommese RF; Sung J; Nag S; Sutton S; Deacon JC; Choe E; Leinwand LA; Ruppel K; Spudich JA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12607-12. PubMed ID: 23798412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics.
    Farman GP; Muthu P; Kazmierczak K; Szczesna-Cordary D; Moore JR
    J Appl Physiol (1985); 2014 Dec; 117(12):1471-7. PubMed ID: 25324513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular genetics of cardiovascular disease.
    Anderson PA
    Curr Opin Cardiol; 1995 Jan; 10(1):33-43. PubMed ID: 7787263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.
    Van Driest SL; Ackerman MJ; Ommen SR; Shakur R; Will ML; Nishimura RA; Tajik AJ; Gersh BJ
    Circulation; 2002 Dec; 106(24):3085-90. PubMed ID: 12473556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite marker analysis in the treatment and diagnosis of familial hypertrophic cardiomyopathy.
    Smolik S; Domal-Kwiatkowska D; Kapral M; Weglarz L
    Acta Pol Pharm; 2010; 67(6):669-72. PubMed ID: 21229884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sudden infant death syndrome gene: does it exist?
    Opdal SH; Rognum TO
    Pediatrics; 2004 Oct; 114(4):e506-12. PubMed ID: 15466077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic changes and clinical management in familial hypertrophic cardiomyopathy].
    Domal-Kwiatkowska D; Smolik S; Mazurek U; Moric E; Polońska J; Nowalany-Kozielska E; Glanowska G; Wodniecki J; Szarek J; Wilczewski P; Kozakiewicz K; Tendera M; Wilczok T
    Wiad Lek; 2000; 53(1-2):4-21. PubMed ID: 10806915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and molecular genetics of hypertrophic cardiomyopathy].
    Sepp R; Csanády M
    Orv Hetil; 1998 Aug; 139(33):1965-71. PubMed ID: 9734214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The left and right ventricle of a patient with a R723G mutation of the beta-myosin heavy chain and severe hypertrophic cardiomyopathy show no differences in the expression of myosin mRNA.
    Borchert B; Tripathi S; Francino A; Navarro-Lopez F; Kraft T
    Cardiol J; 2010; 17(5):518-22. PubMed ID: 20865685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Genetic Basis of Hypertrophic Cardiomyopathy.
    Marian AJ
    Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy.
    Flavigny J; Richard P; Isnard R; Carrier L; Charron P; Bonne G; Forissier JF; Desnos M; Dubourg O; Komajda M; Schwartz K; Hainque B
    J Mol Med (Berl); 1998 Mar; 76(3-4):208-14. PubMed ID: 9535554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.